American Board of Surgery Qualifying Exam (ABS QE) Practice Test

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the American Board of Surgery Qualifying Exam with our interactive quizzes. Utilize detailed flashcards and multiple-choice questions to enhance your learning. Each question is complemented with hints and explanations to help you ace the exam!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


What is the mechanism of action of Sirolimus?

  1. Inhibits calcineurin

  2. Inhibits mTOR and decreases IL-2

  3. Blocks histamine receptors

  4. Depletes T-cell populations

The correct answer is: Inhibits mTOR and decreases IL-2

Sirolimus, also known as rapamycin, primarily functions as an immunosuppressant by inhibiting the mammalian target of rapamycin (mTOR), which is a crucial regulatory protein involved in cell growth, proliferation, and survival. By blocking mTOR, sirolimus effectively reduces the production of cytokines such as interleukin-2 (IL-2), which is essential for T-cell activation and proliferation. This suppression leads to a decrease in T-cell response, making sirolimus particularly useful in preventing organ transplant rejection and in treating certain malignancies. In understanding this mechanism, it's important to recognize that inhibiting mTOR plays a significant role in modulating the immune response, thereby providing its therapeutic effects. The reduction of IL-2 is a direct consequence of mTOR inhibition, highlighting how sirolimus specifically targets pathways involved in T-cell activation and lymphocyte proliferation.